Use of tissue microarray to facilitate oncology research

Area of Science:

• Oncology
• Virology
• Molecular Pathology

Background:

• Human papillomavirus (HPV)-positive oropharyngeal squamous cell carcinomas (OSCC) are distinct from traditional OSCC.
• HPV DNA presence and p16 expression are key indicators of biological relevance in OSCC.

Purpose of the Study:

• To investigate the role of p16 expression in differentiating HPV DNA-positive OSCC.
• To establish distinct molecular and clinical subtypes of OSCC based on HPV and p16 status.
• To compare HPV-positive OSCC with cervical cancer, a known HPV-initiated epithelial cancer model.

Main Methods:

• Real-time polymerase chain reaction (PCR) to determine HPV16 DNA viral load in 79 OSCC cases.
• Tissue microarray (TMA) technology for protein expression analysis.
• Quantitative in situ protein analysis (AQUA) for p53, Rb, and p16 expression.

Main Results:

• Three distinct OSCC subtypes were identified: HPV-negative/p16-nonexpressing, HPV-positive/p16-nonexpressing (HPV-inactive), and HPV-positive/p16-expressing (HPV-active).
• HPV-active tumors exhibited a molecular phenotype similar to cervical cancers.
• HPV-active tumors were associated with a favorable prognosis.

Conclusions:

• HPV DNA and p16 expression status are crucial for classifying OSCC into biologically and clinically distinct subtypes.
• The HPV-active subtype, characterized by p16 expression, represents a favorable prognostic group within HPV-positive OSCC.
• This classification aids in understanding the distinct biology of HPV-driven oropharyngeal cancers.